AKT1 and hypertensive disorder: Luteolin has been demonstrated to inhibit LPS-induced inflammatory responses through modulation of PI3K-Akt signaling in RAW 264.7 cells [52], and it can also reduce hypertension via inhibition of the PI3K/Akt signaling pathway in the hypothalamus [53].